Freedom Capital Markets Maintains Buy on iRhythm Holdings, Lowers Price Target to $159
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Freedom Capital Markets analyst Gene Mannheimer maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $190 to $159.
Freedom Capital Markets analyst Gene Mannheimer maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $190 to $159.